122 related articles for article (PubMed ID: 12431626)
1. An orthotopic aortic graft mouse model to study the immunopathology of chronic vascular rejection.
Thomsen M; Dambrin C; Uro-Coste E; Subra C; Britton S; Joffre O; Calise D; Arbiol C; Thiers JC; Bayard F; Blaes N; Benoist H
Transplant Proc; 2002 Nov; 34(7):2833-5. PubMed ID: 12431626
[No Abstract] [Full Text] [Related]
2. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
Hare GM; Lee TD; Jordan JL; Hirsch GM
Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
[No Abstract] [Full Text] [Related]
3. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
[No Abstract] [Full Text] [Related]
4. Absence of Activation-induced Cytidine Deaminase, a Regulator of Class Switch Recombination and Hypermutation in B Cells, Suppresses Aorta Allograft Vasculopathy in Mice.
Nakanishi T; Xu X; Wynn C; Yamada T; Pan F; Erickson L; Teo H; Nakagawa T; Masunaga T; Abe J; Akamatsu M; Tamura K; Jiang H
Transplantation; 2015 Aug; 99(8):1598-605. PubMed ID: 25769064
[TBL] [Abstract][Full Text] [Related]
5. Development of a mouse aortic transplant model of chronic rejection.
Koulack J; McAlister VC; Giacomantonio CA; Bitter-Suermann H; MacDonald AS; Lee TD
Microsurgery; 1995; 16(2):110-3. PubMed ID: 7783601
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
Tang JL; Woodward JE; Subbotin V; Logar AJ; Sun H; Valdivia LA; Schaefer AT; Zottola LB; Peach R; Fung JJ; Rao AS
Transplant Proc; 2001; 33(1-2):382. PubMed ID: 11266872
[No Abstract] [Full Text] [Related]
7. Endothelin-1 receptor blockade and its effect on chronic rejection.
Tang JL; Aitouche A; Subbotin V; Salam A; Sun H; Gandhi C; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1249. PubMed ID: 10083558
[No Abstract] [Full Text] [Related]
8. Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist.
Amuchastegui S; Daniel KC; Adorini L
Transplantation; 2005 Jul; 80(1):81-7. PubMed ID: 16003237
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 deficiency fails to prevent chronic rejection after aortic allografts in apolipoprotein E-deficient mice.
Yacoub-Youssef H; Blaes N; Calise D; Thiers JC; Therville N; Benoist H; Ségui B; Al Saati T; Thomsen M
J Heart Lung Transplant; 2009 Jan; 28(1):85-92. PubMed ID: 19134536
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporine and some derivatives on chronic rejection.
Lu X; Dawson J; Borel JF
Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221
[No Abstract] [Full Text] [Related]
11. Clinical and experimental chronic allograft rejection.
Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen A; Koskinen P; Ustinov J; Lautenschalger I; Taskinen E
Transplant Proc; 1994 Jun; 26(3):1702-3. PubMed ID: 8030092
[No Abstract] [Full Text] [Related]
12. Chronic graft loss: dealing with the vascular alterations in solid organ transplantation.
Cook NS; Zerwes HG; Rudin M; Beckmann N; Schuurman HJ
Transplant Proc; 1998 Aug; 30(5):2413-8. PubMed ID: 9723522
[No Abstract] [Full Text] [Related]
13. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J
Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
[No Abstract] [Full Text] [Related]
14. Pathophysiology of chronic renal allograft rejection.
Paul LC
Transplant Proc; 1999 Nov; 31(7):2715-6. PubMed ID: 10578262
[No Abstract] [Full Text] [Related]
15. The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection.
Fellström B; Aküyrek LM; Backman U; Jonsson C; Larsson E; Tufveson G; Wahlberg J
Transplant Proc; 1999 Nov; 31(7):2717-8. PubMed ID: 10578263
[No Abstract] [Full Text] [Related]
16. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction.
Bedi DS; Riella LV; Tullius SG; Chandraker A
Transplantation; 2010 Nov; 90(9):935-44. PubMed ID: 20703180
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
[TBL] [Abstract][Full Text] [Related]
18. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection.
Chow LH; Huh S; Jiang J; Zhong R; Pickering JG
Circulation; 1996 Dec; 94(12):3079-82. PubMed ID: 8989111
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular biology of chronic rejection.
Häyry P; Alatalo S; Myllärniemi M; Räisänen-Sokolowski A; Lemström K
Transplant Proc; 1995 Feb; 27(1):71-4. PubMed ID: 7879153
[No Abstract] [Full Text] [Related]
20. Orthotopic aortic transplantation in rodents by the sleeve technique: a model system for the study of graft vascular disease.
Calise D; Dambrin C; Labat A; Pieraggi MT; Pons F; Benoist H; Thomsen M
Transplant Proc; 2001 May; 33(3):2369-70. PubMed ID: 11377562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
